ADMA Biologics
ADMA
ADMA
346 hedge funds and large institutions have $4.08B invested in ADMA Biologics in 2025 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 127 increasing their positions, 111 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
346
Holders Change
+27
Holders Change %
+8.46%
% of All Funds
4.7%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
69
Increased
127
Reduced
111
Closed
36
Calls
$67.2M
Puts
$16.3M
Net Calls
+$50.9M
Net Calls Change
+$22.8M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
$227M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
$22.1M |
| 3 |
D.E. Shaw & Co
New York
|
$30.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$334M |
| 5 |
ACM
Altium Capital Management
New York
|
$0 |
